Pricing Log in Create free account

PainReform Ltd. (PRFX) vs Petros Pharmaceuticals, Inc. (PTPI)

PainReform Ltd. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.3M against $1.0M — 2.2× the size. Across the 8 metrics below, PainReform Ltd. leads on 4 and Petros Pharmaceuticals, Inc. on 4.

Valuation

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.45
P/S n/m n/m 2.11
P/B 0.00 n/m 1.69
Price to free cash flow n/m n/m 15.98
EV/EBITDA 0.97 n/m 12.21
EV/Sales n/m 0.62 2.79
Earnings yield (140,196.48%) 0.00% (15.61%)
Free cash flow yield (91,068.57%) 0.00% 0.00%

Profitability

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 118.32% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% (2.31%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (710.28%) (0.80%)
Return on assets 0.00% (334.15%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (12.20%) 5.22%
EPS growth (last fiscal year) 92.92% 98.13% 42.91%
Revenue growth, 5-year CAGR — (19.98%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 5.07 1.25 2.46
Net debt to EBITDA 0.96 1.11 1.01

Dividend

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.47%
Payout ratio — — 0.28

Size

Metric PRFX PTPI Drug Manufacturers Specialty & Generic median
Market cap 2.31m 1.04m 300.78m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack